ID22414A - Penggunaan kuinoksalina dalam suatu kombinasi tripel dengan penghambat protease dan penghambat transkriptase balik sebagai obat untuk pengobatan aids dan/atau infeksi hiv - Google Patents

Penggunaan kuinoksalina dalam suatu kombinasi tripel dengan penghambat protease dan penghambat transkriptase balik sebagai obat untuk pengobatan aids dan/atau infeksi hiv

Info

Publication number
ID22414A
ID22414A IDW990759A ID990759A ID22414A ID 22414 A ID22414 A ID 22414A ID W990759 A IDW990759 A ID W990759A ID 990759 A ID990759 A ID 990759A ID 22414 A ID22414 A ID 22414A
Authority
ID
Indonesia
Prior art keywords
obstacles
transcryptage
quinoxoxine
tripel
protease
Prior art date
Application number
IDW990759A
Other languages
English (en)
Inventor
Arnold Paessens
Martin Blunck
Gunter Riess
Jorg-Peter Kleim
Manfred Rosner
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID22414A publication Critical patent/ID22414A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW990759A 1997-01-29 1998-01-15 Penggunaan kuinoksalina dalam suatu kombinasi tripel dengan penghambat protease dan penghambat transkriptase balik sebagai obat untuk pengobatan aids dan/atau infeksi hiv ID22414A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (de) 1997-01-29 1997-01-29 Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen

Publications (1)

Publication Number Publication Date
ID22414A true ID22414A (id) 1999-10-14

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990759A ID22414A (id) 1997-01-29 1998-01-15 Penggunaan kuinoksalina dalam suatu kombinasi tripel dengan penghambat protease dan penghambat transkriptase balik sebagai obat untuk pengobatan aids dan/atau infeksi hiv

Country Status (16)

Country Link
EP (1) EP0977570A1 (id)
JP (1) JP2001511124A (id)
KR (1) KR20000070543A (id)
CN (1) CN1251525A (id)
AR (1) AR011094A1 (id)
AU (1) AU6094098A (id)
BR (1) BR9807523A (id)
CA (1) CA2278773A1 (id)
DE (1) DE19703131A1 (id)
ID (1) ID22414A (id)
IL (1) IL130877A0 (id)
NO (1) NO993670L (id)
PL (1) PL334770A1 (id)
SK (1) SK99899A3 (id)
WO (1) WO1998032442A1 (id)
ZA (1) ZA98679B (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
AU6329599A (en) * 1998-09-28 2000-04-17 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl -7-fluoro -3-oxo-3, 4-dihydro -2h-quinoxaline -1-carboxylic acid isopropyl ester
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (es) 2001-03-19 2004-05-05 Astrazeneca Ab Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
EP1962841A1 (en) * 2005-12-15 2008-09-03 Bayer HealthCare AG Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205837T1 (de) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen

Also Published As

Publication number Publication date
NO993670L (no) 1999-09-10
ZA98679B (en) 1998-08-05
AU6094098A (en) 1998-08-18
AR011094A1 (es) 2000-08-02
NO993670D0 (no) 1999-07-28
DE19703131A1 (de) 1998-07-30
KR20000070543A (ko) 2000-11-25
PL334770A1 (en) 2000-03-13
SK99899A3 (en) 2000-03-13
CN1251525A (zh) 2000-04-26
BR9807523A (pt) 2000-03-21
IL130877A0 (en) 2001-01-28
JP2001511124A (ja) 2001-08-07
CA2278773A1 (en) 1998-07-30
EP0977570A1 (de) 2000-02-09
WO1998032442A1 (de) 1998-07-30

Similar Documents

Publication Publication Date Title
ID22414A (id) Penggunaan kuinoksalina dalam suatu kombinasi tripel dengan penghambat protease dan penghambat transkriptase balik sebagai obat untuk pengobatan aids dan/atau infeksi hiv
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
EP0624635A3 (en) Pressure sensitive adhesives for medical use and medical band formed therefrom.
HK1019560A1 (en) Formulation for use in the prevention of pathogen induced diseases including hiv and hsv.
EE9900436A (et) Inimese immuunpuudulikkuse viiruse ja teiste nakkushaiguste mikroobivastane tõkestamine ja käitlemine
ITTO940376A0 (it) Siringa monouso di sicurezza
AU8918998A (en) Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection
AU5732198A (en) Use of the ah receptor and ah receptor ligands to treat or prevent the cytopathicity of viral infection
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
NO941983D0 (no) Engangs-spröyte
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
FI965204A0 (fi) Bromelaiinin lääkekäyttö
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
HUP0200841A2 (en) Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
PT983271E (pt) Hemissulfato carbociclico nucleosidico e a sua utilizacao no tratamento de infeccoes virais
KR950703360A (ko) 미코박테리아 바케로부터의 치료제 및 hiv감염에 대한 그의 사용(therapeutic agent from mycobacterrium vaccae and its use against hiv infection)
FI932847A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids
NO955258D0 (no) Medisinsk anvendelse av enzymer
FI963263A (fi) Bromelaiinin lääkinnällinen käyttö
FI965196A0 (fi) HIV-infektion yhdistelmähoito
IT231828Y1 (it) Siringa di sicurezza monouso.
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
AU1873101A (en) Synergistic treatment of dna viral infections